| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE
SI SK TR |
| (30) |
Priority: |
24.09.2004 WO PCT/GB2004/004112 24.09.2004 WO PCT/GB2004/004132 30.12.2004 US 640498 P
|
| (71) |
Applicant: AstraZeneca AB |
|
S-151 85 Södertälje (SE) |
|
| (72) |
Inventors: |
|
- PAGÈ, Daniel,
AstraZeneca R & D Montreal
St. Laurent, Québec H4S 1Z9 (CA)
- LIU, Ziping,
AstraZeneca R & D Montreal
St. Laurent, Québec H4S 1Z9 (CA)
- TREMBLAY, Maxime,
AstraZeneca R & D Montreal
St. Laurent, Québec H4S 1Z9 (CA)
- WALPOLE, Christopher,
AstraZeneca R & D Montreal
St. Laurent, Québec H4S 1Z9 (CA)
- YANG, Hua,
AstraZeneca R & D Montreal
St. Laurent, Québec H4S 1Z9 (CA)
|
| (74) |
Representative: Wahlström, Stig Christer Gunnar et al |
|
AstraZeneca
Global Intellectual Property 151 85 Södertälje 151 85 Södertälje (SE) |
|